Livent Corp. LTHM
We take great care to ensure that the data presented and summarized in this overview for Livent Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding LTHM
View all-
Met Life Investment Management, LLC Whippany, NJ1.13MShares$5.6 Million0.03% of portfolio
-
Agf Investments Inc. Toronto, A6325KShares$1.61 Million0.09% of portfolio
-
Pfs Investments Inc. Duluth, GA115KShares$569,2450.05% of portfolio
-
Eaton Vance Management Boston, MA98.1KShares$485,5900.0% of portfolio
-
Regent Investment Management LLC58KShares$287,2230.31% of portfolio
-
Bartlett & Co. LLC52KShares$257,5230.02% of portfolio
-
Hnp Capital LLC51KShares$252,4640.31% of portfolio
-
Spouting Rock Asset Management, LLC Bryn Mawr, PA50.5KShares$250,0590.33% of portfolio
-
Virginia Retirement Systems Et Al Richmond, VA40.5KShares$200,4750.01% of portfolio
-
Brinker Capital Investments, LLC23.8KShares$117,9280.01% of portfolio
Latest Institutional Activity in LTHM
Top Purchases
Top Sells
About LTHM
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.
Insider Transactions at LTHM
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 04
2024
|
Robert C Pallash Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
79,977
-100.0%
|
-
|
Jan 04
2024
|
Pierre R Brondeau Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
405,421
-100.0%
|
-
|
Jan 04
2024
|
G Peter Daloia Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
44,716
-100.0%
|
-
|
Jan 04
2024
|
G Peter Daloia Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
162,464
-100.0%
|
-
|
Jan 04
2024
|
Paul W Graves President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
97,815
-100.0%
|
-
|
Jan 04
2024
|
Paul W Graves President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
355,541
-100.0%
|
-
|
Jan 04
2024
|
Sara Ponessa VP, Gen. Counsel & Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
48,359
-100.0%
|
-
|
Jan 04
2024
|
Michael F Barry Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
67,350
-100.0%
|
-
|
Jan 04
2024
|
Pablo Marcet Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
32,307
-100.0%
|
-
|
Jan 04
2024
|
Pablo Marcet Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
7,000
-100.0%
|
-
|
Jan 04
2024
|
Steven T Merkt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
49,525
-100.0%
|
-
|
Jan 04
2024
|
Christina Lampe Onnerud Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
32,307
-100.0%
|
-
|
Jan 04
2024
|
Gilberto Antoniazzi Vice President and CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
77,991
-100.0%
|
-
|
Jan 04
2024
|
Ronald B Stark Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,018
-100.0%
|
-
|
Jan 04
2024
|
Andrea E Utecht Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
146,199
-100.0%
|
-
|
Dec 22
2023
|
Ronald B Stark Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
682
-2.63%
|
$10,912
$16.44 P/Share
|
Dec 22
2023
|
Ronald B Stark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,200
+7.82%
|
-
|
Dec 22
2023
|
Sara Ponessa VP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,624
-2.72%
|
$41,984
$16.44 P/Share
|
Dec 22
2023
|
Sara Ponessa VP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
8,479
+8.09%
|
-
|
Dec 22
2023
|
Gilberto Antoniazzi Vice President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,402
-2.19%
|
$54,432
$16.44 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 64.5K shares |
---|
Sale (or disposition) back to the issuer | 1.62M shares |
---|---|
Payment of exercise price or tax liability | 30.4K shares |